The R403Q Myosin Mutation Implicated in Familial Hypertrophic Cardiomyopathy Causes Disorder at the Actomyosin Interface

Background Mutations in virtually all of the proteins comprising the cardiac muscle sarcomere have been implicated in causing Familial Hypertrophic Cardiomyopathy (FHC). Mutations in the β-myosin heavy chain (MHC) remain among the most common causes of FHC, with the widely studied R403Q mutation resulting in an especially severe clinical prognosis. In vitro functional studies of cardiac myosin containing the R403Q mutation have revealed significant changes in enzymatic and mechanical properties compared to wild-type myosin. It has been proposed that these molecular changes must trigger events that ultimately lead to the clinical phenotype. Principal Findings Here we examine the structural consequences of the R403Q mutation in a recombinant smooth muscle myosin subfragment (S1), whose kinetic features have much in common with slow β-MHC. We obtained three-dimensional reconstructions of wild-type and R403Q smooth muscle S1 bound to actin filaments in the presence (ADP) and absence (apo) of nucleotide by electron cryomicroscopy and image analysis. We observed that the mutant S1 was attached to actin at highly variable angles compared to wild-type reconstructions, suggesting a severe disruption of the actin-myosin interaction at the interface. Significance These results provide structural evidence that disarray at the molecular level may be linked to the histopathological myocyte disarray characteristic of the diseased state.

[1]  D A Winkelmann,et al.  Three-dimensional structure of myosin subfragment-1: a molecular motor. , 1993, Science.

[2]  Niels Volkmann,et al.  Evidence for cleft closure in actomyosin upon ADP release , 2000, Nature Structural Biology.

[3]  V. Ferrans,et al.  Myocardial Ultrastructure in Idiopathic Hypertrophic Subaortic Stenosis: A Study of Operatively Excised Left Ventricular Outflow Tract Muscle in 14 Patients , 1972, Circulation.

[4]  C. Moncman,et al.  Mutations in the motor domain modulate myosin activity and myofibril organization , 2003, Journal of Cell Science.

[5]  S. Margossian Reversible dissociation of dog cardiac myosin regulatory light chain 2 and its influence on ATP hydrolysis. , 1985, The Journal of biological chemistry.

[6]  M. Peckham,et al.  Heterologous expression of wild‐type and mutant β‐cardiac myosin changes the contractile kinetics of cultured mouse myotubes , 2003, The Journal of physiology.

[7]  A J Marian,et al.  A transgenic rabbit model for human hypertrophic cardiomyopathy. , 1999, The Journal of clinical investigation.

[8]  Guiping Yang,et al.  An α-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes. , 1999, American journal of physiology. Heart and circulatory physiology.

[9]  Kathleen M. Trybuss Regulation of Expressed Truncated Smooth Muscle Myosins , 1994 .

[10]  D. DeRosier,et al.  Reconstruction of three-dimensional images from electron micrographs of structures with helical symmetry. , 1970, Journal of molecular biology.

[11]  N. Alpert,et al.  Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. , 1995, Circulation research.

[12]  J. Seidman,et al.  The Genetic Basis for Cardiomyopathy from Mutation Identification to Mechanistic Paradigms , 2001, Cell.

[13]  K. Trybus Regulation of expressed truncated smooth muscle myosins. Role of the essential light chain and tail length. , 1994, The Journal of biological chemistry.

[14]  T. Pollard,et al.  Three-dimensional Structure of Acanthamoeba castellanii Myosin-IB (MIB) Determined by Cryoelectron Microscopy of Decorated Actin Filaments , 1998, The Journal of cell biology.

[15]  J. Spudich,et al.  Purification of muscle actin. , 1982, Methods in enzymology.

[16]  J. Sellers,et al.  The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy. , 1997, Journal of muscle research and cell motility.

[17]  N. Volkmann,et al.  The Structural Basis of Myosin V Processive Movement as Revealed by Electron Cryomicroscopy , 2022 .

[18]  Niels Volkmann,et al.  Myosin isoforms show unique conformations in the actin-bound state , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. D. Pardee,et al.  [18] Purification of muscle actin , 1982 .

[20]  D. DeRosier,et al.  Evidence for a Conformational Change in Actin Induced by Fimbrin (N375) Binding , 1997, The Journal of cell biology.

[21]  L. Leinwand,et al.  Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. , 1994, The Journal of biological chemistry.

[22]  E. Egelman A robust algorithm for the reconstruction of helical filaments using single-particle methods. , 2000, Ultramicroscopy.

[23]  PhD Jil C. Tardiff MD,et al.  Sarcomeric Proteins and Familial Hypertrophic Cardiomyopathy: Linking Mutations in Structural Proteins to Complex Cardiovascular Phenotypes , 2005, Heart Failure Reviews.

[24]  Roberto Dominguez,et al.  Crystal Structure of a Vertebrate Smooth Muscle Myosin Motor Domain and Its Complex with the Essential Light Chain Visualization of the Pre–Power Stroke State , 1998, Cell.

[25]  B. Hainque,et al.  Familial hypertrophic cardiomyopathy: from mutations to functional defects. , 1998, Circulation research.

[26]  Daniel Safer,et al.  Myosin VI is an actin-based motor that moves backwards , 1999, Nature.

[27]  A new algorithm to align three-dimensional maps of helical structures. , 1999, Ultramicroscopy.

[28]  H. Sugi,et al.  Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication. , 1997, The Journal of clinical investigation.

[29]  M. Geeves,et al.  The Slow Skeletal Muscle Isoform of Myosin Shows Kinetic Features Common to Smooth and Non-muscle Myosins* , 2006, Journal of Biological Chemistry.

[30]  Michael Whittaker,et al.  A 35-Å movement of smooth muscle myosin on ADP release , 1995, Nature.

[31]  Reconstruction of symmetry deviations: a procedure to analyze partially decorated F-actin and other incomplete structures. , 1998, Ultramicroscopy.

[32]  Rasmus R. Schröder,et al.  Electron cryo-microscopy shows how strong binding of myosin to actin releases nucleotide , 2003, Nature.

[33]  J. Sellers,et al.  The in vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hypertrophic cardiomyopathy , 1997, Journal of Muscle Research & Cell Motility.

[34]  Niels Volkmann,et al.  A novel three-dimensional variant of the watershed transform for segmentation of electron density maps. , 2002, Journal of structural biology.

[35]  Carl A. Morris,et al.  A structural state of the myosin V motor without bound nucleotide , 2003, Nature.

[36]  Frederick J. Schoen,et al.  A Mouse Model of Familial Hypertrophic Cardiomyopathy , 1996, Science.

[37]  Matthew J. Tyska,et al.  R403Q and L908V mutant β-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level , 2004, Journal of Muscle Research & Cell Motility.

[38]  D. DeRosier,et al.  Three-dimensional structure of the frozen-hydrated flagellar filament. The left-handed filament of Salmonella typhimurium. , 1987, Journal of molecular biology.

[39]  W Chiu,et al.  EMAN: semiautomated software for high-resolution single-particle reconstructions. , 1999, Journal of structural biology.

[40]  J. Seidman,et al.  Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. , 2000, Circulation research.

[41]  L. Leinwand,et al.  Animal models of hypertrophic cardiomyopathy. , 2000, Current opinion in cardiology.

[42]  R A Milligan,et al.  Structure of the actin-myosin complex and its implications for muscle contraction. , 1993, Science.

[43]  Anne Houdusse,et al.  Three myosin V structures delineate essential features of chemo‐mechanical transduction , 2004, The EMBO journal.

[44]  M. Kollmar,et al.  Crystal structure of the motor domain of a class‐I myosin , 2002, The EMBO journal.

[45]  M. Ikebe,et al.  Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome. , 1996, The Journal of clinical investigation.

[46]  D G Morgan,et al.  Image analysis of helical objects: the Brandeis Helical Package. , 1996, Journal of structural biology.

[47]  M. Tyska,et al.  Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy. , 2000, The Journal of biological chemistry.

[48]  N. Volkmann,et al.  Quantitative fitting of atomic models into observed densities derived by electron microscopy. , 1999, Journal of structural biology.

[49]  J. Seidman,et al.  A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.